Nutritional management for Alzheimer’s disease in all stages: mild, moderate, and severe
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2316-7874
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nutritional management for Alzheimer’s disease in all stages: mild, moderate, and severe ; volume:42 ; number:1 ; day:10 ; month:1 ; year:2017 ; pages:1-6 ; date:12.2017
Nutrire ; 42, Heft 1 (10.1.2017), 1-6, 12.2017
- Schlagwort
-
Ernährung
Ernährungsberatung
Diätetik
- Urheber
-
Pivi, Glaucia Akiko Kamikado
- Beteiligte Personen und Organisationen
-
Vieira, Neusa Maria de Andrade
da Ponte, Jaqueline Botelho
de Moraes, Débora Santos Coca
Bertolucci, Paulo Henrique Ferreira
SpringerLink (Online service)
- DOI
-
10.1186/s41110-016-0025-7
- URN
-
urn:nbn:de:1111-201701311205
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pivi, Glaucia Akiko Kamikado
- Vieira, Neusa Maria de Andrade
- da Ponte, Jaqueline Botelho
- de Moraes, Débora Santos Coca
- Bertolucci, Paulo Henrique Ferreira
- SpringerLink (Online service)
Ähnliche Objekte (12)
Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
Automated detection of early-stage Alzheimer’s Disease
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis
Language impairment in the moderate stage of dementia due to Alzheimer's disease
Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease
Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
Zulassungserweiterung - Memantine auch bei moderater Alzheimer-Demenz
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
Oral Health Status and Nutritional Habits as Predictors for Developing Alzheimer’s Disease
Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?
Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease
Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
Automated detection of early-stage Alzheimer’s Disease
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis
Language impairment in the moderate stage of dementia due to Alzheimer's disease
Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease
Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
Zulassungserweiterung - Memantine auch bei moderater Alzheimer-Demenz
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
Oral Health Status and Nutritional Habits as Predictors for Developing Alzheimer’s Disease
Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?
Dysphagia is closely related to frailty in mild-to-moderate Alzheimer’s disease
Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
Automated detection of early-stage Alzheimer’s Disease
Rivastigmine in moderately severe-to-severe Alzheimer’s disease: Severe Impairment Battery factor analysis
Language impairment in the moderate stage of dementia due to Alzheimer's disease
Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease
Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease
Zulassungserweiterung - Memantine auch bei moderater Alzheimer-Demenz
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms
Oral Health Status and Nutritional Habits as Predictors for Developing Alzheimer’s Disease
Severe COVID-19 in Alzheimer’s disease: APOE4’s fault again?